Parkman Healthcare Partners
Latest statistics and disclosures from Parkman Healthcare Partners's latest quarterly 13F-HR filing:
- Top 5 stock holdings are BSX, PODD, DXCM, SYK, CVS, and represent 19.00% of Parkman Healthcare Partners's stock portfolio.
- Added to shares of these 10 stocks: DXCM (+$28M), MASI (+$26M), EYPT (+$20M), WAT (+$16M), MTD (+$15M), SYK (+$15M), A (+$14M), ANIP (+$11M), UNH (+$11M), LIVN (+$8.3M).
- Started 20 new stock positions in ANIP, ABSI, ACHC, EYPT, INSP, UNH, ALGN, CAI, ARAY, SENS. WAT, TMDX, MTD, GPCR, ADMA, CDNA, ADPT, MDLN, A, MASI.
- Reduced shares in these 10 stocks: QQQ (-$48M), BIIB (-$17M), ALNY (-$16M), TERN (-$13M), CSTL (-$13M), DHR (-$12M), VRDN (-$11M), TVTX (-$9.7M), , ZBH (-$9.0M).
- Sold out of its positions in ABVX, ASND, BMRN, TVRD, DVAX, INCY, QQQ, LLY, MASS, OM. UTHR.
- Parkman Healthcare Partners was a net seller of stock by $-35M.
- Parkman Healthcare Partners has $1.1B in assets under management (AUM), dropping by 9.57%.
- Central Index Key (CIK): 0001777015
Tip: Access up to 7 years of quarterly data
Positions held by Parkman Healthcare Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Parkman Healthcare Partners
Parkman Healthcare Partners holds 100 positions in its portfolio as reported in the December 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Boston Scientific Corporation (BSX) | 4.5 | $48M | +15% | 501k | 95.35 |
|
| Insulet Corporation (PODD) | 3.8 | $40M | +21% | 141k | 284.24 |
|
| Dex (DXCM) | 3.7 | $39M | +242% | 588k | 66.37 |
|
| Stryker Corporation (SYK) | 3.5 | $37M | +64% | 106k | 351.47 |
|
| CVS Caremark Corporation (CVS) | 3.4 | $36M | +18% | 450k | 79.36 |
|
| McKesson Corporation (MCK) | 2.8 | $30M | +27% | 36k | 820.29 |
|
| Kalvista Pharmaceuticals (KALV) | 2.7 | $29M | 1.8M | 16.15 |
|
|
| Mbx Biosciences (MBX) | 2.7 | $28M | +14% | 886k | 31.54 |
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 2.6 | $27M | 665k | 41.25 |
|
|
| Masimo Corporation (MASI) | 2.5 | $26M | NEW | 200k | 130.06 |
|
| Livanova SHS (LIVN) | 2.4 | $25M | +48% | 411k | 61.53 |
|
| Terns Pharmaceuticals (TERN) | 2.4 | $25M | -33% | 621k | 40.40 |
|
| Miragen Therapeutics (VRDN) | 2.3 | $25M | -31% | 788k | 31.12 |
|
| Arcus Biosciences Incorporated (RCUS) | 2.2 | $23M | +48% | 969k | 23.83 |
|
| Upstream Bio (UPB) | 2.2 | $23M | 835k | 27.15 |
|
|
| Qiagen Nv Com Shs | 2.1 | $22M | 494k | 44.97 |
|
|
| Amicus Therapeutics (FOLD) | 2.0 | $21M | -11% | 1.5M | 14.24 |
|
| Eyepoint Com New (EYPT) | 1.9 | $20M | NEW | 1.1M | 18.27 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.8 | $19M | -45% | 48k | 397.65 |
|
| Neurocrine Biosciences (NBIX) | 1.5 | $16M | -19% | 115k | 141.83 |
|
| Waters Corporation (WAT) | 1.5 | $16M | NEW | 42k | 379.83 |
|
| Mettler-Toledo International (MTD) | 1.5 | $15M | NEW | 11k | 1394.19 |
|
| Mineralys Therapeutics (MLYS) | 1.4 | $15M | -9% | 410k | 36.29 |
|
| Stoke Therapeutics (STOK) | 1.3 | $14M | +72% | 430k | 31.74 |
|
| Agilent Technologies Inc C ommon (A) | 1.3 | $14M | NEW | 100k | 136.07 |
|
| Zimmer Holdings (ZBH) | 1.3 | $14M | -39% | 151k | 89.92 |
|
| Danaher Corporation (DHR) | 1.3 | $14M | -46% | 59k | 228.92 |
|
| Xeris Pharmaceuticals (XERS) | 1.3 | $13M | -5% | 1.7M | 7.85 |
|
| Edwards Lifesciences (EW) | 1.2 | $13M | -3% | 151k | 85.25 |
|
| Ptc Therapeutics I (PTCT) | 1.2 | $12M | -20% | 160k | 75.96 |
|
| Waystar Holding Corp (WAY) | 1.2 | $12M | +20% | 369k | 32.75 |
|
| Syndax Pharmaceuticals (SNDX) | 1.1 | $12M | -32% | 574k | 21.01 |
|
| Tenet Healthcare Corp Com New (THC) | 1.1 | $12M | -18% | 61k | 198.72 |
|
| Nuvalent Inc-a (NUVL) | 1.1 | $12M | 119k | 100.59 |
|
|
| Biosante Pharmaceuticals (ANIP) | 1.1 | $11M | NEW | 145k | 78.94 |
|
| Edgewise Therapeutics (EWTX) | 1.0 | $11M | -22% | 428k | 24.82 |
|
| UnitedHealth (UNH) | 1.0 | $11M | NEW | 32k | 330.11 |
|
| Cooper Cos (COO) | 1.0 | $10M | -28% | 125k | 81.96 |
|
| CryoLife (AORT) | 0.9 | $10M | 219k | 45.61 |
|
|
| Apogee Therapeutics (APGE) | 0.9 | $9.8M | +22% | 130k | 75.48 |
|
| Maze Therapeatics (MAZE) | 0.8 | $8.7M | +4% | 209k | 41.43 |
|
| Assembly Biosciences Com New (ASMB) | 0.8 | $8.5M | 249k | 34.01 |
|
|
| Arcellx Common Stock (ACLX) | 0.8 | $8.4M | -14% | 128k | 65.20 |
|
| Axogen (AXGN) | 0.8 | $8.2M | -50% | 250k | 32.73 |
|
| Iqvia Holdings (IQV) | 0.8 | $7.9M | +17% | 35k | 225.41 |
|
| Si-bone (SIBN) | 0.7 | $7.4M | 374k | 19.72 |
|
|
| Doximity Cl A (DOCS) | 0.7 | $7.2M | -9% | 162k | 44.28 |
|
| BioCryst Pharmaceuticals (BCRX) | 0.7 | $7.0M | -11% | 900k | 7.80 |
|
| Xenon Pharmaceuticals (XENE) | 0.7 | $6.9M | -12% | 154k | 44.82 |
|
| Optimizerx Corp Com New (OPRX) | 0.6 | $6.6M | +5% | 539k | 12.26 |
|
| Adaptive Biotechnologies Cor (ADPT) | 0.6 | $6.5M | NEW | 402k | 16.24 |
|
| Biogen Idec (BIIB) | 0.6 | $6.2M | -72% | 35k | 175.99 |
|
| Uniqure Nv SHS (QURE) | 0.6 | $6.2M | -25% | 257k | 23.93 |
|
| Day One Biopharmaceuticals I (DAWN) | 0.6 | $6.0M | +113% | 646k | 9.32 |
|
| Immunome (IMNM) | 0.6 | $6.0M | -20% | 278k | 21.48 |
|
| Castle Biosciences (CSTL) | 0.6 | $5.9M | -68% | 151k | 38.90 |
|
| Alphatec Hldgs Com New (ATEC) | 0.6 | $5.8M | -60% | 277k | 21.04 |
|
| Transmedics Group (TMDX) | 0.5 | $5.5M | NEW | 45k | 121.65 |
|
| Schrodinger (SDGR) | 0.5 | $5.3M | -12% | 299k | 17.88 |
|
| Quidel Corp (QDEL) | 0.5 | $5.3M | -27% | 185k | 28.56 |
|
| Caredx (CDNA) | 0.5 | $5.2M | NEW | 276k | 18.84 |
|
| Genedx Holdings Corp Com Cl A (WGS) | 0.5 | $5.1M | -13% | 39k | 130.06 |
|
| Vera Therapeutics Cl A (VERA) | 0.5 | $5.1M | +3% | 101k | 50.64 |
|
| Absci Corp (ABSI) | 0.5 | $5.1M | NEW | 1.5M | 3.49 |
|
| Amylyx Pharmaceuticals (AMLX) | 0.4 | $4.6M | -34% | 382k | 12.08 |
|
| Inspiremd (NSPR) | 0.4 | $4.3M | 2.4M | 1.78 |
|
|
| Veracyte (VCYT) | 0.4 | $4.2M | -55% | 100k | 42.10 |
|
| Precigen (PGEN) | 0.4 | $4.2M | -52% | 1.0M | 4.18 |
|
| Spyre Therapeutics Com New (SYRE) | 0.4 | $4.1M | -37% | 125k | 32.76 |
|
| Urogen Pharma (URGN) | 0.4 | $4.0M | -58% | 169k | 23.42 |
|
| Align Technology (ALGN) | 0.4 | $3.9M | NEW | 25k | 156.15 |
|
| Structure Therapeutics Sponsored Ads (GPCR) | 0.4 | $3.8M | NEW | 55k | 69.55 |
|
| 4d Molecular Therapeutics In (FDMT) | 0.4 | $3.8M | +151% | 503k | 7.50 |
|
| Rxsight (RXST) | 0.3 | $3.7M | -7% | 352k | 10.42 |
|
| Adma Biologics (ADMA) | 0.3 | $3.6M | NEW | 200k | 18.24 |
|
| Mannkind Corp Com New (MNKD) | 0.3 | $3.6M | -2% | 640k | 5.67 |
|
| Caris Life Sciences (CAI) | 0.3 | $3.4M | NEW | 125k | 26.98 |
|
| Travere Therapeutics (TVTX) | 0.3 | $3.3M | -74% | 86k | 38.21 |
|
| Certara Ord (CERT) | 0.3 | $3.1M | -36% | 349k | 8.81 |
|
| Annexon (ANNX) | 0.3 | $3.0M | +48% | 601k | 5.02 |
|
| CVRX (CVRX) | 0.3 | $2.9M | -15% | 413k | 7.10 |
|
| Agios Pharmaceuticals (AGIO) | 0.3 | $2.7M | 100k | 27.22 |
|
|
| Solid Biosciences Com New (SLDB) | 0.2 | $2.4M | +5% | 418k | 5.64 |
|
| Protagonist Therapeutics (PTGX) | 0.2 | $2.3M | -58% | 26k | 87.34 |
|
| Quanterix Ord (QTRX) | 0.2 | $2.1M | +30% | 329k | 6.36 |
|
| Pulmonx Corp (LUNG) | 0.2 | $1.6M | +45% | 728k | 2.21 |
|
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $1.4M | -9% | 62k | 23.00 |
|
| Acadia Healthcare (ACHC) | 0.1 | $1.4M | NEW | 100k | 14.19 |
|
| Inspire Med Sys (INSP) | 0.1 | $1.4M | NEW | 15k | 92.23 |
|
| Senseonics Hldgs (SENS) | 0.1 | $1.1M | NEW | 207k | 5.52 |
|
| Crinetics Pharmaceuticals In (CRNX) | 0.1 | $1.1M | -69% | 23k | 46.55 |
|
| Rapid Micro Biosystems Class A Com (RPID) | 0.1 | $1.0M | -61% | 355k | 2.90 |
|
| Medline Com Cl A (MDLN) | 0.1 | $863k | NEW | 21k | 42.00 |
|
| Accuray Incorporated (ARAY) | 0.1 | $703k | NEW | 852k | 0.82 |
|
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $686k | 100k | 6.90 |
|
|
| Entera Bio SHS (ENTX) | 0.1 | $534k | -2% | 275k | 1.94 |
|
| Edap Tms S A Sponsored Adr (EDAP) | 0.0 | $509k | 155k | 3.29 |
|
|
| Treace Med Concepts (TMCI) | 0.0 | $489k | -76% | 199k | 2.45 |
|
| Butterfly Network Com Cl A (BFLY) | 0.0 | $383k | -83% | 101k | 3.80 |
|
| Ovid Therapeutics (OVID) | 0.0 | $328k | 201k | 1.63 |
|
Past Filings by Parkman Healthcare Partners
SEC 13F filings are viewable for Parkman Healthcare Partners going back to 2019
- Parkman Healthcare Partners 2025 Q4 filed Feb. 17, 2026
- Parkman Healthcare Partners 2025 Q3 filed Nov. 14, 2025
- Parkman Healthcare Partners 2025 Q2 filed Aug. 14, 2025
- Parkman Healthcare Partners 2025 Q1 filed May 15, 2025
- Parkman Healthcare Partners 2024 Q4 filed Feb. 14, 2025
- Parkman Healthcare Partners 2024 Q3 filed Nov. 14, 2024
- Parkman Healthcare Partners 2024 Q2 filed Aug. 14, 2024
- Parkman Healthcare Partners 2024 Q1 filed May 15, 2024
- Parkman Healthcare Partners 2023 Q3 filed Nov. 14, 2023
- Parkman Healthcare Partners 2023 Q2 filed Aug. 11, 2023
- Parkman Healthcare Partners 2023 Q1 filed May 12, 2023
- Parkman Healthcare Partners 2022 Q4 filed Feb. 13, 2023
- Parkman Healthcare Partners 2022 Q3 filed Nov. 14, 2022
- Parkman Healthcare Partners 2022 Q2 filed Aug. 12, 2022
- Parkman Healthcare Partners 2022 Q1 filed May 13, 2022
- Parkman Healthcare Partners 2021 Q4 filed Feb. 11, 2022